SCIVERSE SOLUTIONS PRIVATE LIMITED

In their own words

"The Indian healthcare sector is facing numerous challenges in the realm of blood testing and the delivery of accurate diagnoses to patients. One of the major challenges is the current system of sending blood samples to centralized laboratories for analysis, which often results in delays that can last several days. These prolonged waiting periods are not only a source of inconvenience for patients and healthcare providers, but they can also have a negative impact on patient outcomes. This is because diagnostic results are essential to guide the patient's plan of care during the consultation, and unnecessary delays in treatment can have serious consequences.Additionally, the existing blood analyzers used in the healthcare sector are not only cost-prohibitive, but they are also large in size and perform limited tests. This restricts their use in resource-constrained settings and remote areas, where access to healthcare is limited. Furthermore, the requirement for trained lab technicians to operate these devices represents a significant barrier to widespread usage.To address these challenges, there is a growing demand for a diagnostic device that can provide real-time, lab-quality results in a point-of-care setting while ensuring patient safety and compliance with regulatory standards. The shift from volume- to value-based care has made point-of-care testing an essential tool for improving the quality of patient-provider interactions. Providers want to have diagnostic results available in real-time to guide the patient's plan of care during their consultation, instead of waiting for test results and unnecessarily delaying treatment.The COVID-19 pandemic has further emphasized the importance of accessible healthcare testing, highlighting the need to expand access to real-time testing so that individuals can make informed decisions about their health and well-being. The pandemic has accelerated the move towards point-of-care (POC) testing, which provides consumers with the ability to access healthcare testing from their local drugstore or the comfort of their own homes. The broad range of COVID-19 testing options demonstrates the urgency of curbing the spread of the virus at both individual and community levels.However, this shift towards POC testing represents a turning point for patient testing, as it provides a continuous stream of patient data, enabling new models of health promotion and maintenance to emerge and evolve over time. By leveraging innovative technologies such as microfluidics, machine vision, and AI, POC testing can deliver real-time, lab-quality results in a portable, user-friendly device that is accessible to healthcare providers and patients, regardless of location. This means that patients in remote and resource-constrained settings will have access to the same level of care as those in urban areas.In conclusion, the future of diagnostic technology is poised to revolutionize the way we approach blood testing and patient care in India. The growing demand for POC testing devices, which provide real-time, lab-quality results, is driving the development of innovative technologies such as microfluidics, machine vision, and AI. These technologies are helping to create user-friendly, accessible devices that are poised to change the way healthcare is delivered in India. The shift towards POC testing is a turning point for patient testing, providing a continuous stream of patient data and enabling new models of health promotion and maintenance to emerge and evolve over time."

Written by the company on its public Startup India profile. Not verified by us.